1. Home
  2. APGE vs DRH Comparison

APGE vs DRH Comparison

Compare APGE & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • DRH
  • Stock Information
  • Founded
  • APGE 2022
  • DRH 2004
  • Country
  • APGE United States
  • DRH United States
  • Employees
  • APGE N/A
  • DRH N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • DRH Real Estate Investment Trusts
  • Sector
  • APGE Health Care
  • DRH Real Estate
  • Exchange
  • APGE Nasdaq
  • DRH Nasdaq
  • Market Cap
  • APGE 2.0B
  • DRH 1.7B
  • IPO Year
  • APGE 2023
  • DRH 2005
  • Fundamental
  • Price
  • APGE $37.87
  • DRH $8.59
  • Analyst Decision
  • APGE Strong Buy
  • DRH Hold
  • Analyst Count
  • APGE 5
  • DRH 6
  • Target Price
  • APGE $95.40
  • DRH $8.63
  • AVG Volume (30 Days)
  • APGE 431.7K
  • DRH 2.5M
  • Earning Date
  • APGE 08-11-2025
  • DRH 08-07-2025
  • Dividend Yield
  • APGE N/A
  • DRH 3.74%
  • EPS Growth
  • APGE N/A
  • DRH N/A
  • EPS
  • APGE N/A
  • DRH 0.28
  • Revenue
  • APGE N/A
  • DRH $1,124,753,000.00
  • Revenue This Year
  • APGE N/A
  • DRH N/A
  • Revenue Next Year
  • APGE N/A
  • DRH $2.31
  • P/E Ratio
  • APGE N/A
  • DRH $30.72
  • Revenue Growth
  • APGE N/A
  • DRH 1.72
  • 52 Week Low
  • APGE $26.20
  • DRH $6.19
  • 52 Week High
  • APGE $63.50
  • DRH $10.00
  • Technical
  • Relative Strength Index (RSI)
  • APGE 51.33
  • DRH 65.18
  • Support Level
  • APGE $35.68
  • DRH $8.32
  • Resistance Level
  • APGE $38.75
  • DRH $8.63
  • Average True Range (ATR)
  • APGE 1.59
  • DRH 0.17
  • MACD
  • APGE 0.19
  • DRH 0.03
  • Stochastic Oscillator
  • APGE 69.51
  • DRH 85.19

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.

Share on Social Networks: